ALICIA SCHULTZ: Open Payments
NPI 1720232556 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$596 in 21 payments from 13 companies in 2025. Trend: 2023 $228 · 2024 $63 · 2025 $596
Food & beverage: $596
| Company | Payments | Amount |
|---|---|---|
| Adaptive Biotechnologies Corporation | 1 | $138 |
| ABBVIE INC. | 5 | $102 |
| Janssen Biotech, Inc. | 2 | $58 |
| TerSera Therapeutics LLC | 2 | $50 |
| Genentech USA, Inc. | 2 | $49 |
| SOBI, INC | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| KYOWA KIRIN, INC. | 1 | $28 |
| Incyte Corporation | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $21 |
Products named: clonoSEQ, RYBREVANT, Zoladex, EPKINLY, Doptelet, VENCLEXTA, Polivy, KOMZIFTI.
Industry payments across OK — which companies pay providers there.
